☆ 4.2 Meeting Abstract

Somatic Mutational Landscape and Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors Among Patients With Myeloid and Lymphoid Neoplasms With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, FGFR1, JAK2, or FLT3

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2022)

Add to Collection

Journal

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Volume 22, Issue -, Pages S341-S341

Publisher

CIG MEDIA GROUP, LP

Keywords

MPN; myeloid and lymphoid neoplasms with eosinophilia (MLN-Eos); somatic mutational landscape; tyrosine kinase inhibitor (TKI); gene fusion

Categories

Oncology Hematology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.